Detailed Narrative
Expansion Gestation Hits the Bottom Line
KIMS is currently in the most intensive phase of its expansion strategy, having launched 7 new hospitals in 2025 alone. While this drove a 29.2% YoY increase in revenue from operations to ₹998 crores, it caused a significant 550 bps contraction in EBITDA margins to 20.4%. The resulting PAT of ₹52 crores was a sharp decline from ₹93 crores in the previous year, reflecting the high initial costs, depreciation, and interest associated with these new assets.
New Unit Breakeven Trajectory
Management provided a clear roadmap for the stabilization of new units. The Nashik facility turned EBITDA positive in January 2026, its 13th month of operation, with ₹8.5 crores in monthly revenue. Thane and Mahadevapura (Bangalore) are expected to reach EBITDA breakeven by the end of Q1 FY27, while the recently commissioned Electronic City unit is targeted for breakeven by Q3 FY27. This sequential stabilization is critical for margin recovery.
Telangana and Andhra Cluster Dynamics
The mature Telangana cluster continues to grow at 20% YoY, though reported occupancy of 52.5% is misleading due to 200-250 beds being under renovation in Secunderabad; available bed occupancy is actually 80-85%. In Andhra Pradesh, volumes were temporarily hit by a 45-60 day strike related to the Aarogyasri government scheme, though management noted that revenues bounced back to Q2 levels by January.
Debt Peak and Receivables Challenge
Net debt has climbed to ₹2,850 crores, but management signaled this is the peak as the 3-year capex cycle concludes. A significant portion of the debt is linked to ₹600 crores in pending receivables from state and central governments. Bhaskara Bollineni emphasized that as these payments arrive and new units stabilize, debt will start 'coming down quarter-on-quarter' without the need for incremental borrowing.
Strategic Entry into Chennai
KIMS has finalized an agreement to operate a hospital in Chennai for 26 years, with construction expected to finish in 2 years. This move is described as the 'missing link' in consolidating their presence across South India. Management believes the KIMS brand already has strong goodwill in Tamil Nadu due to the large Telugu-speaking population and existing patient flows from Andhra Pradesh.